Entry Detail



General Information

Database ID:TRD00105
Confidence:High
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:tRF5-GluCTC
tsRNA Type:5'-tiRNA
Amino acid and Anticodon:GluCTC
Sequence:TCCCTGGTGGTCTAGTGGTTAGGATTCGGCGCT
Related Target:N/A
Predicted Target:TFCP2L1//EME2//RFTN1//TMEM92//PAQR4//CCDC159//SLC25A48//SLC25A6//TMEM69//CHRNB4
External Links:
MINTbase ID:tRF-33-87R8WP9N1EWJDW
tRFdb ID:N/A

[1] gtRNAdb_ID:tRNA-Glu-CTC-2-1
Anticodon:GluCTC
tRNA_number:trna59
Chromosome:1
Strand:+
Coordinate:Start Site(bp): 249168447        End Site(bp): 249168479

[2] gtRNAdb_ID:tRNA-Glu-CTC-1-1
Anticodon:GluCTC
tRNA_number:trna116
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 145399272        End Site(bp): 145399304

[3] gtRNAdb_ID:tRNA-Glu-CTC-1-5
Anticodon:GluCTC
tRNA_number:trna71
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161439228        End Site(bp): 161439260

[4] gtRNAdb_ID:tRNA-Glu-CTC-1-4
Anticodon:GluCTC
tRNA_number:trna74
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161431848        End Site(bp): 161431880

[5] gtRNAdb_ID:tRNA-Glu-CTC-1-3
Anticodon:GluCTC
tRNA_number:trna77
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161424437        End Site(bp): 161424469

[6] gtRNAdb_ID:tRNA-Glu-CTC-1-2
Anticodon:GluCTC
tRNA_number:trna80
Chromosome:1
Strand:-
Coordinate:Start Site(bp): 161417057        End Site(bp): 161417089

[7] gtRNAdb_ID:tRNA-Glu-CTC-1-6
Anticodon:GluCTC
tRNA_number:trna77
Chromosome:6
Strand:+
Coordinate:Start Site(bp): 28949976        End Site(bp): 28950008

[8] gtRNAdb_ID:tRNA-Glu-CTC-1-7
Anticodon:GluCTC
tRNA_number:trna87
Chromosome:6
Strand:-
Coordinate:Start Site(bp): 126101432        End Site(bp): 126101464



tsRNA Association Statistics

Total Associated Disease Number:9
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D000544DOID:10652
Disease Name:Alzheimer DiseaseAlzheimer's disease
Category:MeSHDisease Ontology
Type:Nervous System Diseases//Mental Disordersdisease of anatomical entity
Define:A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)A tauopathy that is characterized by memory lapses, confusion, emotional instability and progressive loss of mental ability and results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood starting and leads in advanced cases to a profound decline in cognitive and physical functioning and is marked histologically by the degeneration of brain neurons especially in the cerebral cortex and by the presence of neurofibrillary tangles and plaques containing beta-amyloid.
Alias:Acute Confusional Senile Dementia//Alzheimer Dementia//Alzheimer Disease, Early Onset//Alzheimer Disease, Late Onset//Alzheimer Sclerosis//Alzheimer Syndrome//Alzheimer Type Senile Dementia//Alzheimer's Disease//Alzheimer's Disease, Focal Onset//Alzheimer's Diseases//Alzheimer-Type Dementia (ATD)//Dementia, Alzheimer Type//Dementia, Presenile//Dementia, Primary Senile Degenerative//Dementia, Senile//Early Onset Alzheimer Disease//Familial Alzheimer Disease (FAD)//Focal Onset Alzheimer's Disease//Late Onset Alzheimer Disease//Presenile Alzheimer Dementia//Primary Senile Degenerative Dementia//Senile Dementia, Acute Confusional//Senile Dementia, Alzheimer TypeAlzheimer disease//Alzheimers dementia



Disease Association Statistics

Total Associated tsRNA Number:151
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:RT-qPCR/Transfection/ELISA
Weak Evidence:High-throughput sequencing



Reference

[1] PubMed ID:33337366
Disease Name:Alzheimer Disease
Tissue:Brain
Dysfunction Pattern:N/A
Validated Method:RT-qPCR/Transfection/ELISA//High-throughput sequencing
Description:AD is the most common form of dementia seen in late life, accounting for 60–80% of dementia cases [1]. In 2017, 121,404 patients died of AD, makingAD the sixth leading cause of death in the United States [42]. In this study, we identified the altered expression of tRFs and their putative biogenesis controllers in the hippocampus ofADpatients, providing newpotential insight into the understanding of AD progression.
Comparision:Disease VS Control
Mechanism:tRF5-GlyGCC and tRF5-GluCTC were reported to play important roles in various biological processes, including sperm maturation [47], RSV infection [13, 14], and breast cancer progression [48]. These two tRF5s were also significantly increased in the EOAD group and also showed an enhanced tendency in the LOAD group. In the future, more samples need to be requested to define the importance of these two tRFs in the LOAD. These two tRF5s are inducible by overexpression of ANG in cells, and the exposure of secreted ANG causes a complete cleavage of their parental tRNAs in vitro [49]. Interestingly,ANG cleavage is very tRNA type-specific. ANG overexpression in cells usually only cleaves one or two specific isodecoders (tRNAs with the same anticodon but different sequences elsewhere) of tRNA, while other isodecoders and isoacceptors (different tRNAs encoding the same amino acids with different anticodons) are not cleavable, suggesting a precise cellular control mechanism underlying ANG-mediated tRNA cleavage. Similar results were also observed in other tRF5s’ expression in AD.